Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid

By Wild J.   Gruner B.   Metzger K.   Kuhrober A.   Pudollek H.-P.   Hauser H.   Schirmbeck R.   Reimann J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 353-360

Elsevier

Access to resources Recommend Favorite

Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw 2 , adr, ayw 3 ) in measuring the immune response after vaccination

By Heijtink R.A.   Bergen P.v.   Melber K.   Janowicz Z.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2191-2196

Elsevier

Access to resources Recommend Favorite

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

By West D.J.   Calandra G.B.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1019-1027

Elsevier

Access to resources Recommend Favorite

A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine

By Young M.D.   Rosenthal M.H.   Dickson B.   Du W.   Maddrey W.C.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3437-3443

Elsevier

Access to resources Recommend Favorite

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

By Kwissa M.   von Kampen v.K.J.   Zurbriggen R.   Gluck R.   Reimann J.   Schirmbeck R.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2337-2344

Elsevier

Access to resources Recommend Favorite